TKP nedeniyle hastanede yatan yaşlı hastaların (>65 yaş) özellikleri ve maliyeti analiz edildi.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Amaç: Toplum kökenli pnömoni (TKP) nedeniyle yaşlı hastaların hastane yatış sıklığı yüksektir ve hastane maliyetini arttırır.
📊
Temel Bulgular & Veri:Amaç: Toplum kökenli pnömoni (TKP) nedeniyle yaşlı hastaların hastane yatış sıklığı yüksektir ve hastane maliyetini arttırır.
💡
Sonuç & Katkı:TKP nedeniyle hastanede yatan yaşlı hastaların (>65 yaş) özellikleri ve maliyeti analiz edildi.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:yaşlı · hastane yatışı · toplum kökenli pnömoni
Özet
Amaç: Toplum kökenli pnömoni (TKP) nedeniyle yaşlı hastaların hastane yatış sıklığı yüksektir ve hastane maliyetini arttırır. TKP nedeniyle hastanede yatan yaşlı hastaların (>65 yaş) özellikleri ve maliyeti analiz edildi.
Abstract
Objective: The prevalence hospitalization of elderly patients due to community acquired pneumonia (CAP) is high and increases the hospital cost. Characteristics and economic burden of hospitalized elderly patients (>65years) due to CAP were analyzed.
KATGI, N., ÇİMEN, P., AYRANCI, A., TUKSAVUL, F. F. (2022). Toplumdan Kökenli Pnömoni Nedeniyle Hastanede Yatan Yaşlı Hastaların (> 65 Yaş) Özellikleri ve Ekonomik Yükü. Abant Tıp Dergisi, Cilt: 11 - Sayı: 1, 84–91. https://ajindex.com/articles/448526
Referans 1. Egger ME, Myers JA, Arnold FW, Pass LA, Ramirez JA, Brock GN. Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia. BioMed Central Medical Informatics and Decision Making 2016 Mar 15;16:34. doi: 10.1186/s12911-016-0270-y Referans 2. Chen L, Zhou F, Li H, Xing X, Han X, Wang Y, et al. Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey. British Medical Journal Open 2018 Feb 15;8(2):e018709. doi: 10.1136/bmjopen-2017-018709. Referans 3. Almirall J, Bolíbar I, Vidal J, Sauca G, Coll P, Niklasson B, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. European Respiratory Journal 2000 Apr;15(4):757-63. doi: 10.1034/j.1399-3003.2000.15d21.x. Referans 4. Cilloniz C, Rodrigues-Hurtado D, Torres A. Characteristics and management of community-acquired pneumonia in the era of global aging. Medical Science 2018, 6(2):35. doi: 10.3390/medsci6020035. Referans 5. World Population Prospects: The 2017 Revision I Multimedia Library- United Nations Department of Economic and Social Affairs. Available online: https://www.un.org/development/desa7publications/world-population-prospects-the-2017-revision.html(accessed on 9 February 2018). Referans 6. Konomura K, Nagai H, Akazawa M. Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective. Pneumonia (Nathan). 2017 Dec 5;9:19. doi: 10.1186/s41479-017-0042-1. Referans 7. Brown JD, Harnett J, Chambers R, Sato R. The relative burden of community-acquired pneumonia hospitalizations in older adults: a retrospective observational study in the United States. BioMed Central Geriatrics. 2018 Apr 16;18(1):92. doi: 10.1186/s12877-018-0787-2. Referans 8. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Şarkıcı DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. The New England Journal of Medicine 1997 Jan 23;336(4):243-50. doi: 10.1056/NEJM199701233360402. Referans 9. Sato R, Gomez Rey G, Nelson S, Pinsky B. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years. Applied Health Economics and Health Policy 2013 Jun;11(3):251-8. doi: 10.1007/s40258-013-0026-0. Referans 10. File TM Jr, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgraduate Medicine 2010 Mar;12